136 related articles for article (PubMed ID: 31087233)
1. Dosimetric validation of the Theragenics AgX-100® I-125 seed for ROPES eye plaque brachytherapy.
Pagulayan C; Heng SM; Corde S
Australas Phys Eng Sci Med; 2019 Jun; 42(2):599-609. PubMed ID: 31087233
[TBL] [Abstract][Full Text] [Related]
2. I-125 ROPES eye plaque dosimetry: validation of a commercial 3D ophthalmic brachytherapy treatment planning system and independent dose calculation software with GafChromic® EBT3 films.
Poder J; Corde S
Med Phys; 2013 Dec; 40(12):121709. PubMed ID: 24320495
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
5. Novel application of 3D printing in brachytherapy using MED610 3D printed insert for I-125 ROPES eye plaque.
Sim L
Australas Phys Eng Sci Med; 2016 Dec; 39(4):863-870. PubMed ID: 27730458
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
Lesperance M; Martinov M; Thomson RM
Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
[TBL] [Abstract][Full Text] [Related]
7. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
[TBL] [Abstract][Full Text] [Related]
8. ROPES eye plaque brachytherapy dosimetry for two models of (103)Pd seeds.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Australas Phys Eng Sci Med; 2011 Jun; 34(2):223-31. PubMed ID: 21452056
[TBL] [Abstract][Full Text] [Related]
9. Investigating the dosimetric impact of seed location uncertainties in Collaborative Ocular Melanoma Study-based eye plaques.
Johnson JE; Deufel CL; Furutani KM
Brachytherapy; 2016; 15(5):661-8. PubMed ID: 27475484
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric study of the 15 mm ROPES eye plaque.
Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry and physical treatment planning for iodine eye plaque therapy.
Alberti W; Pothmann B; Tabor P; Muskalla K; Hermann KP; Harder D
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1087-92. PubMed ID: 2022510
[TBL] [Abstract][Full Text] [Related]
12. Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy.
Morrison H; Menon G; Larocque MP; Jans HS; Weis E; Sloboda RS
Med Phys; 2016 Aug; 43(8):4891. PubMed ID: 27487906
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous dose calculations for Collaborative Ocular Melanoma Study eye plaques using actual seed configurations and Task Group Report 43 formalism.
Deufel CL; Furutani KM
Brachytherapy; 2015; 14(2):209-30. PubMed ID: 25533415
[TBL] [Abstract][Full Text] [Related]
14. Episcleral eye plaque dosimetry comparison for the Eye Physics EP917 using Plaque Simulator and Monte Carlo simulation.
Zimmermann LW; Amoush A; Wilkinson DA
J Appl Clin Med Phys; 2015 Nov; 16(6):226-239. PubMed ID: 26699577
[TBL] [Abstract][Full Text] [Related]
15. Dosimetry for 125I seed (model 6711) in eye plaques.
Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy.
Knutsen S; Hafslund R; Monge OR; Valen H; Muren LP; Rekstad BL; Krohn J; Dahl O
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1159-66. PubMed ID: 11704341
[TBL] [Abstract][Full Text] [Related]
17. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
Miras H; Terrón JA; Lallena AM
Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
[TBL] [Abstract][Full Text] [Related]
18. Experimental determination of the Task Group-43 dosimetric parameters of the new I25.S17plus (125)I brachytherapy source.
Moutsatsos A; Pantelis E; Papagiannis P; Baltas D
Brachytherapy; 2014; 13(6):618-26. PubMed ID: 25108795
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric calculations and measurements of gold plaque ophthalmic irradiators using iridium-192 and iodine-125 seeds.
Luxton G; Astrahan MA; Liggett PE; Neblett DL; Cohen DM; Petrovich Z
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):167-76. PubMed ID: 3391814
[TBL] [Abstract][Full Text] [Related]
20. 125I eye plaque dose distribution including penumbra characteristics.
de la Zerda A; Chiu-Tsao ST; Lin J; Boulay LL; Kanna I; Kim JH; Tsao HS
Med Phys; 1996 Mar; 23(3):407-18. PubMed ID: 8815384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
